Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorbald van Hall

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Cancer Gene Therapy|November 24, 2018
Arming oncolytic reovirus with GM-CSF gene to enhance immunityVera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, et al.
Cancer Immunology Research|June 23, 2017
CD4<sup>+</sup> T Cell and NK Cell Interplay Key to Regression of MHC Class I<sup>low</sup> Tumors upon TLR7/8 Agonist TherapyElien M Doorduijn, Marjolein Sluijter, Daniela C Salvatori, et al.
Oncotarget|December 15, 2015
The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinomaMehrdad Talebian Yazdi, Sander van Riet, Annemarie van Schadewijk, et al.
Molecular Cancer Therapeutics|November 2, 2018
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective MemoryHreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter, et al.
Plos One|August 12, 2014
Inhibition of CSF-1R supports T-cell mediated melanoma therapyMarjolein Sluijter, Tetje C van der Sluis, Pieter A van der Velden, et al.
Plos One|January 7, 2022
Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studiesSomayeh Rostamian, Saskia le Cessie, Koen A Marijt, et al.
Cancer Cell|December 10, 2024
Myeloid effector cells in cancerPieter Schol, Marit J van Elsas, Jim Middelburg, et al.
European Journal of Immunology|August 14, 2013
Proline substitution independently enhances H-2D(b) complex stabilization and TCR recognition of melanoma-associated peptidesHannes Uchtenhagen, Esam T Abualrous, Evi Stahl, et al.
Molecular Cancer Therapeutics|June 22, 2022
Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy EfficacyFloris Dammeijer, Mandy van Gulijk, Larissa Klaase, et al.
Cancer Immunology Research|May 25, 2017
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC ImmunotherapyFloris Dammeijer, Lysanne A Lievense, Margaretha E Kaijen-Lambers, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Cancer Gene Therapy|November 24, 2018
Arming oncolytic reovirus with GM-CSF gene to enhance immunityVera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, et al.
Cancer Immunology Research|June 23, 2017
CD4<sup>+</sup> T Cell and NK Cell Interplay Key to Regression of MHC Class I<sup>low</sup> Tumors upon TLR7/8 Agonist TherapyElien M Doorduijn, Marjolein Sluijter, Daniela C Salvatori, et al.
Oncotarget|December 15, 2015
The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinomaMehrdad Talebian Yazdi, Sander van Riet, Annemarie van Schadewijk, et al.
Molecular Cancer Therapeutics|November 2, 2018
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective MemoryHreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter, et al.
Plos One|August 12, 2014
Inhibition of CSF-1R supports T-cell mediated melanoma therapyMarjolein Sluijter, Tetje C van der Sluis, Pieter A van der Velden, et al.
Plos One|January 7, 2022
Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studiesSomayeh Rostamian, Saskia le Cessie, Koen A Marijt, et al.
Cancer Cell|December 10, 2024
Myeloid effector cells in cancerPieter Schol, Marit J van Elsas, Jim Middelburg, et al.
European Journal of Immunology|August 14, 2013
Proline substitution independently enhances H-2D(b) complex stabilization and TCR recognition of melanoma-associated peptidesHannes Uchtenhagen, Esam T Abualrous, Evi Stahl, et al.
Molecular Cancer Therapeutics|June 22, 2022
Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy EfficacyFloris Dammeijer, Mandy van Gulijk, Larissa Klaase, et al.
Cancer Immunology Research|May 25, 2017
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC ImmunotherapyFloris Dammeijer, Lysanne A Lievense, Margaretha E Kaijen-Lambers, et al.
Pageof 13